Johannes P van Hooff Selected Research

Johannes P van Hooff Research Topics

7	Diabetes Mellitus 02/2008 - 01/2002
6	Insulin Resistance 09/2017 - 01/2002
2	Neoplasms (Cancer) 01/2020 - 01/2004
2	Atrophy 06/2012 - 01/2004
2	Hyperlipidemias (Hyperlipidemia) 07/2006 - 01/2002
2	Hypertension (High Blood Pressure) 07/2006 - 01/2004
2	Weight Gain 05/2003 - 01/2002
1	Opportunistic Infections (Opportunistic Infection) 01/2020
1	Fibrosis (Cirrhosis) 06/2012
1	Pathologic Constriction (Stenosis) 01/2009
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2009
1	Hyperplasia 01/2009
1	Muscle Weakness 04/2007
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2006
1	Serum Sickness 01/2006
1	Delayed Graft Function 11/2005
1	Long Term Adverse Effects 01/2004
1	Obesity 01/2004
1	Osteoporosis 01/2004
1	Hypercholesterolemia 06/2003
1	Body Weight (Weight, Body) 05/2003
1	Infections 07/2002
1	Hepatitis C 07/2002
1	Glucose Metabolism Disorders 01/2002

7	Tacrolimus (Prograf)FDA LinkGeneric 01/2020 - 01/2002
5	SteroidsIBA 09/2017 - 01/2002
5	Glucose (Dextrose)FDA LinkGeneric 09/2017 - 01/2002
4	Insulin (Novolin)FDA Link 09/2017 - 01/2002
3	LDL CholesterolIBA 07/2006 - 01/2002
3	CholesterolIBA 07/2006 - 01/2002
3	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2004 - 05/2003
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2009 - 01/2004
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2008 - 01/2002
2	C-PeptideIBA 01/2002 - 01/2002
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 06/2012
1	Sirolimus (Rapamycin)FDA Link 06/2012
1	2- cyano- 3- hydroxy- N- (4- (trifluoromethyl)phenyl)- 2- hepten- 6- ynamideIBA 01/2009
1	Antiviral Agents (Antivirals)IBA 01/2009
1	Pharmaceutical PreparationsIBA 01/2009
1	Azathioprine (Imuran)FDA LinkGeneric 01/2004
1	LipidsIBA 01/2002
1	Triglycerides (Triacylglycerol)IBA 01/2002
1	Prednisolone (Predate)FDA LinkGeneric 01/2002
1	HDL CholesterolIBA 01/2002

9	Kidney Transplantation 06/2012 - 01/2002
1	Renal Dialysis (Hemodialysis) 04/2007
1	Plasmapheresis 01/2006
1	Transplantation 11/2005
1	Therapeutics 12/2004
1	Drug Tapering 12/2004